The Pharmaceutical Benefits Scheme has served the Australian community well, according to Jan Donovan In this article she argues that increases in the present system of 'copayments' for medicines will not contribute to improving the equity, effectiveness or efficiency of the health system, particularly for those using the health system most.

Foreword Building a safe, high-quality health care system means that people managing and working in the system need to work together with consumers and the community to achieve sustainable improvements and maintain public confidence in the system. The Consumer Focus Collaboration publication series provides practical tools to support consumer and health care providers to achieve...

This paper focuses on projecting acute care hospital costs for public and private patients, and government expenditure on benefits paid for Medical Benefits Schedule (MBS) items and Pharmaceutical Benefits Schedule (PBS) items in the context of an ageing population.

The National School Drug Education Strategy was prepared by the National Advisory Committee on School Drug Education after extensive consultation with education, health and law enforcement professionals, parent groups, individuals and community organisations with its fundamental goal being “no illicit drugs in schools”. The National School Drug Education Strategy demonstrates the Commonwealth Government’s recognition that...